Detalhe da pesquisa
1.
DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice.
Am J Physiol Renal Physiol
; 320(3): F505-F517, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33522410
2.
The global spectrum of protein-coding pharmacogenomic diversity.
Pharmacogenomics J
; 18(1): 187-195, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27779249
3.
A novel microdeletion affecting the CETP gene raises HDL-associated cholesterol levels.
Clin Genet
; 89(4): 495-500, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26126777
4.
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.
Pharmacogenomics J
; 14(2): 160-70, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23588107
5.
Pharmacogenomic diversity in Singaporean populations and Europeans.
Pharmacogenomics J
; 14(6): 555-63, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861855
6.
Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results.
Clin Genet
; 85(4): 303-11, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24256063
7.
Personalized gene silencing therapeutics for Huntington disease.
Clin Genet
; 86(1): 29-36, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24646433
8.
Use of genetic technologies to compare medicines.
Clin Genet
; 86(5): 441-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25046029
9.
The emerging era of pharmacogenomics: current successes, future potential, and challenges.
Clin Genet
; 86(1): 21-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24684508
10.
Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families.
Clin Genet
; 85(5): 433-40, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23701270
11.
Developing a comprehensive, effective patient-friendly website to enhance decision making in predictive testing for Huntington disease.
Genet Med
; 15(6): 466-72, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23222664
12.
Providing predictive testing for Huntington disease via telehealth: results of a pilot study in British Columbia, Canada.
Clin Genet
; 84(1): 60-4, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23039041
13.
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.
Pediatr Blood Cancer
; 60(8): 1375-81, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23441093
14.
"Grasping the grey": patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease.
J Genet Couns
; 22(2): 200-17, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22903792
15.
Exclusion of DNA changes in the beta-subunit of the c-GMP phosphodiesterase gene as the cause for Huntington's disease.
Nat Genet
; 1(2): 104-8, 1992 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-1338767
16.
Delineation of a 50 kilobase DNA segment containing the recombination site in a sporadic case of Huntington's disease.
Nat Genet
; 2(3): 216-22, 1992 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-1345172
17.
HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain.
Nat Genet
; 16(1): 44-53, 1997 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-9140394
18.
Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.
Nat Genet
; 18(2): 150-4, 1998 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-9462744
19.
Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.
Nat Genet
; 13(4): 442-9, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8696339
20.
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.
Nat Genet
; 22(4): 336-45, 1999 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10431236